A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)

PHASE2/PHASE3TerminatedINTERVENTIONAL
Enrollment

189

Participants

Timeline

Start Date

July 9, 2020

Primary Completion Date

July 20, 2022

Study Completion Date

July 20, 2022

Conditions
PneumoniaCOVID-19Coronavirus
Interventions
DRUG

PTC299

Oral tablets

OTHER

SOC

As defined per local written policies or guidelines.

DRUG

Placebo

Oral tablets

Trial Locations (41)

1000

St. Pierre University Hospital, Brussels

1500

Worthwhile Clinical Trials, Benoni

3168

Monash Medical Centre, Clayton

4058

Ahmed Al-Kadi Private Hospital, Durban

7500

TREAD Research, Cape Town

7530

Tiervlei Trial Centre, Cape Town

21287

Johns Hopkins Hospital, Baltimore

28031

Hospital Universitario Infanta Leonor, Madrid

28034

Hospital Universitario Ramón y Cajal, Madrid

28041

Hospital 12 de Octubre, Madrid

28702

Hospital Universitario Infanta Sofía, San Sebastián de los Reyes

29401

Ralph H. Johnson VA Medical Center, Charleston

30912

Augusta University, Augusta

36520

Centro Hospitalario MAC, Irapuato

44106

University Hospitals Cleveland, Cleveland

64460

Hospital Universitario Dr. José Eleuterio Gonzalez, Monterrey

72410

Integra RGH Centro de Investigación/ Hospital MAC Puebla, Puebla City

75013

Hôpital Pitié-Salpêtrière, Paris

91910

SOMECO - Sociedad de Metabolismo y Corazón S.C., Veracruz

92868

University of California, Irvine, Orange

110311

Fundación Santa Fe de Bogotá, Bogotá

01605

University of Massachusetts Memorial Health Care, Worcester

02145

Westmead Hospital, Westmead

03021

Sunshine Hospital, St Albans

B-1340

Clinique Saint Pierre, Ottignies

30190-130

Hospital Vera Cruz, Belo Horizonte

90035-000

Hospital Moinhos de Vento, Porto Alegre

89204-061

Centro Hospitalar Unimed (CHU) - Joinville, Joinville

11045-904

Hospital Guilherme Alvaro, Santos

01508-000

Hospital Alemao Oswaldo Cruz, São Paulo

04023-062

Escola Paulista de Medicina (UNIFESP), São Paulo

15090-000

Fundação Faculdade Regional de Medicina de São José do Rio Preto, São Paulo

18013-000

Hospital Santa Casa de Misecórdia de Sorocoba, Sorocaba

054040

Centro Cardiovascular Somer Incare, Rionegro

02-507

Central Clinic Hospital of the MSWiA in Warsaw, Warsaw

1649-035

Centro Hospitalar Universitário de Lisboa Norte (CHULN), E.P.E - Hospital de Santa Maria, Lisbon

4520-211

Centro Hospitalar de Entre o Douro e Vouga, EPE (CHEDV), Santa Maria da Feira

4434-502

Centro Hospitalar de Vila Nova de Gaia/Espinho, EPE (CHVNG/E), Vila Nova de Gaia

0001

Global Clinical Trials, Pretoria

08003

Hospital Del Mar, Barcelona

08907

Hospital Universitario de Bellvitge, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

PTC Therapeutics

INDUSTRY

NCT04439071 - A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) | Biotech Hunter | Biotech Hunter